Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

MHRA grants approval to Cortex to initiate study of CX-1739 in sleep apnea

Jan. 28, 2009

GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model

Jan. 28, 2009

CLK-1 inhibition may explain the effect of clioquinol in neurodegenerative diseases

Jan. 28, 2009

EpiCept reports positive results from phase IIb EpiCept trial

Jan. 28, 2009

MAP completes patient enrollment in phase III clinical trial of MAP-0004

Jan. 27, 2009

Glenmark files phase I trial application with MHPRA for GRC-15300

Jan. 26, 2009

FDA approves Geron's IND for phase I clinical trial of GRNOPC-1 in spinal cord injury

Jan. 26, 2009

Cladribine significantly reduced relapse rate of MS in phase III pivotal trial

Jan. 26, 2009

Fenobam safe, affects behavior in patients with Fragile X syndrome

Jan. 26, 2009

Solvay claims novel cannabinoid CB1 receptor agonists for use as analgesic agents

Jan. 26, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...